The paper stresses that taking preventive and socio-economic measures to combat TB would be more cost-effective than the treatment of a TB case, particularly, in a developing-country context. Therefore, it is suggested that the anti-tubercular chemotherapy treatment in a developing country should be scrutinised in comparison with socio-economic measures to control TB on several recommended lines.